Pharvaris CMO sells 29,700 shares after option exercise
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Pharvaris N.V. Chief Medical Officer Lu Peng reported a series of option exercises and related share sales. On June 25–26, 2026, she exercised stock options covering 29,700 shares of common stock at a $2.59 exercise price and sold 29,700 shares in open-market transactions under a Rule 10b5-1 trading plan using cashless exercises. Reported weighted average sale prices were about $34.45, $35.09, and $34.00, each reflecting multiple trades within narrow price ranges. Following these transactions, Peng holds 65,631 shares of Pharvaris common stock directly.
Insider Trade Summary 10b5-1
Exercise and Sale: 29,700 shares ($942K approx. pre-tax spread)
Exercise and Sale
7 txns
Insider
Lu Peng
Role
Chief Medical Officer
Sold
29,700 shs ($1.02M)
Approx. gross sale proceeds
$1.02M
Approx. exercise cost
$77K
Approx. pre-tax spread
$942K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 14,700 | $0.00 | $0.00 |
| Exercise | Common Stock | 14,700 | $2.59 | $38K |
| Sale | Common Stock | 14,700 | $34.0032 | $500K |
| Exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,000 | $2.59 | $39K |
| Sale | Common Stock | 11,600 | $34.4547 | $400K |
| Sale | Common Stock | 3,400 | $35.0913 | $119K |
Holdings After Transaction:
Stock Option (Right to Buy) — 175,308 contracts (Direct);
Common Stock — 65,631 shares (Direct)
Footnotes (5)
- F1. This is a scheduled exercise and sale from 10b5-1 trading plan.
- F2. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $34.00 to $34.98. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F3. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $35.00 to 35.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F4. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $34.00 to 34.02. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F5. 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.
Key Figures
Shares sold: 29,700 shares
Shares exercised: 29,700 shares
Exercise price: $2.59 per share
+4 more
7 metrics
Shares sold
29,700 shares
Total common shares sold in open-market transactions on June 25–26, 2026
Shares exercised
29,700 shares
Common shares acquired through stock option exercises on June 25–26, 2026
Exercise price
$2.59 per share
Stock option exercise price for 29,700 common shares
Sale price 1
$34.4547 per share
Weighted average sale price for 11,600 shares of common stock on June 25, 2026
Sale price 2
$35.0913 per share
Weighted average sale price for 3,400 shares of common stock on June 25, 2026
Sale price 3
$34.0032 per share
Weighted average sale price for 14,700 shares of common stock on June 26, 2026
Post-transaction holdings
65,631 shares
Common stock directly owned by Lu Peng after reported transactions
Key Terms
Rule 10b5-1 trading plan, cashless exercise, weighted average sale price, Stock Option (Right to Buy), +1 more
5 terms
Rule 10b5-1 trading plan financial
"transactions on the reported date pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
cashless exercise financial
"shares were sold in connection with the exercise of stock options in a cashless exercise transaction"
A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.
weighted average sale price financial
"The reported price represents a weighted average sale price for shares sold in multiple transactions"
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
vesting financial
"25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Pharvaris (PHVS) report for Lu Peng?
Pharvaris reported that Chief Medical Officer Lu Peng exercised stock options for 29,700 shares and sold 29,700 shares of common stock. These transactions occurred on June 25–26, 2026 as part of pre-arranged activity under a Rule 10b5-1 trading plan.
What was the exercise price of Lu Peng’s Pharvaris (PHVS) stock options?
Lu Peng’s exercised stock options carried a $2.59 per share exercise price. She exercised options covering a total of 29,700 shares of Pharvaris common stock on June 25–26, 2026, then sold the same number of shares in related open-market transactions.
Was Lu Peng’s Pharvaris (PHVS) stock sale pre-planned under Rule 10b5-1?
Yes. The footnotes state the sales were executed pursuant to a Rule 10b5-1 trading plan. Such plans pre-schedule trades, meaning the timing of these June 2026 cashless exercise and sale transactions was established in advance rather than decided opportunistically.
What is meant by cashless exercise in Lu Peng’s Pharvaris (PHVS) Form 4?
The filing notes that shares were sold in connection with option exercises in a cashless exercise transaction. In this structure, part or all of the exercised shares are sold immediately, and sale proceeds cover the $2.59 per share exercise cost and related obligations.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates